Abbvie Inc
BMV:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbvie Inc
BMV:ABBV
|
US |
|
Amplify Energy Corp
NYSE:AMPY
|
US |
|
Old Dominion Freight Line Inc
NASDAQ:ODFL
|
US |
|
V
|
Verisign Inc
F:VRS
|
US |
|
G
|
Greencoat Renewables PLC
ISEQ:GRP
|
IE |
|
MDA Ltd
TSX:MDA
|
CA |
|
F
|
Frontier Lithium Inc
OTC:LITOF
|
CA |
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
Illumina Inc
NASDAQ:ILMN
|
US |
|
ChipMOS Technologies Inc
NASDAQ:IMOS
|
TW |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 4 274.6725 MXN with a low forecast of 3 149.5616 MXN and a high forecast of 5 716.2513 MXN.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
4 274.6725
MXN
According to Wall Street analysts, the average 1-year price target for ABBV is 4 274.6725 MXN with a low forecast of 3 149.5616 MXN and a high forecast of 5 716.2513 MXN.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 11%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 32%.
